{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T23:27:56Z","timestamp":1773444476610,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejmp.2022.08.001","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T05:57:49Z","timestamp":1660543069000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Analysis of dose to the macula, optic disc, and lens in relation to vision toxicities \u2013 A retrospective study using COMS eye plaques"],"prefix":"10.1016","volume":"101","author":[{"given":"Courtney","family":"Oare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Dusenbery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dara","family":"Koozekanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Gerbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2022.08.001_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/107327480401100504","article-title":"The collaborative ocular melanoma study: An overview","volume":"11","author":"Margo","year":"2004","journal-title":"Cancer Control"},{"key":"10.1016\/j.ejmp.2022.08.001_b0010","doi-asserted-by":"crossref","unstructured":"Melia BM, Abramson DH, Albert DM, Boldt HC, Earle JD, Hanson WF, et al. Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma: I. Visual acuity after 3 years, COMS Report No. 16. Ophthalmology 2001;108:348\u201366. https:\/\/doi.org\/10.1016\/S0161-6420(00)00526-1.","DOI":"10.1016\/S0161-6420(00)00526-1"},{"issue":"5","key":"10.1016\/j.ejmp.2022.08.001_b0015","doi-asserted-by":"crossref","DOI":"10.1002\/mp.13996","article-title":"AAPM recommendations on medical physics practices for ocular plaque brachytherapy: Report of task group 221","volume":"47","author":"Thomson","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2022.08.001_b0020","doi-asserted-by":"crossref","unstructured":"Marr B. The COMS randomized trail of iodine 125 brachytherapy for choroidal melanoma: Twelve-yeare mortality rates and prognostic factors: COMS Report No. 28. Evidence-Based Eye Care 2007;8:156\u20138.","DOI":"10.1097\/IEB.0b013e31809fe256"},{"issue":"5","key":"10.1016\/j.ejmp.2022.08.001_b0025","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ophtha.2012.10.021","article-title":"Scleral necrosis after plaque radiotherapy of uveal melanoma: A case-control study","volume":"120","author":"Kaliki","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejmp.2022.08.001_b0030","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0360-3016(93)90310-R","article-title":"Radiation dose to the lens and cataract formation","volume":"25","author":"Henk","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ejmp.2022.08.001_b0035","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: Report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2022.08.001_b0040","first-page":"1724","article-title":"Intraocular radiation blocking","volume":"31","author":"Finger","year":"1990","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ejmp.2022.08.001_b0045","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","article-title":"The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas","volume":"56","author":"Nag","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2022.08.001_b0050","doi-asserted-by":"crossref","unstructured":"Nanda S, Reynolds S, Kaiser P. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22. Evidence-Based Eye Care 2004;5:206\u20137.","DOI":"10.1097\/01.ieb.0000142780.51926.02"},{"key":"10.1016\/j.ejmp.2022.08.001_b0055","doi-asserted-by":"crossref","unstructured":"COMS Group. Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: The Collaborative Ocular Melanoma Study. COMS Report No. 3. Control Clin Trials 1993;14:362\u201391. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/0197-2456(93)90052-F.","DOI":"10.1016\/0197-2456(93)90052-F"},{"key":"10.1016\/j.ejmp.2022.08.001_b0060","first-page":"1230","article-title":"Ocular melanoma: An overview of the current status","volume":"6","author":"Jovanovic","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.ejmp.2022.08.001_b0065","doi-asserted-by":"crossref","unstructured":"Takiar V, Voong KR, Gombos DS, Mourtada F, Rechner LA, Lawyer AA, et al. A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma. Pract Radiat Oncol 2015;5:e169\u201376. https:\/\/doi.org\/10.1016\/j.prro.2014.09.005.","DOI":"10.1016\/j.prro.2014.09.005"},{"key":"10.1016\/j.ejmp.2022.08.001_b0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.brachy.2011.01.006","article-title":"A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using 125I, 103Pd, and 131Cs and historical perspective","volume":"10","author":"Leonard","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ejmp.2022.08.001_b0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5114\/jcb.2018.77849","article-title":"Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: Part I","volume":"10","author":"Miguel","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.ejmp.2022.08.001_b0080","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1167\/iovs.04-0066","article-title":"Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: Empirical data and simulation of collimating plaques","volume":"45","author":"Puusaari","year":"2004","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ejmp.2022.08.001_b0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00195358","article-title":"Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru\/106Rh plaques","volume":"232","author":"Lommatzsch","year":"1994","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ejmp.2022.08.001_b0090","series-title":"Retin","first-page":"289","article-title":"Radiation retinopathy","author":"Kim","year":"2006"},{"key":"10.1016\/j.ejmp.2022.08.001_b0095","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00417-008-0920-6","article-title":"Scleral necrosis after radiation therapy for uveal melanomas: Report of 23 cases","volume":"246","author":"Radin","year":"2008","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ejmp.2022.08.001_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/950975","article-title":"Outcomes and control rates for I-125 plaque brachytherapy for uveal melanoma: A community-based institutional experience","volume":"2014","author":"Wagner","year":"2014","journal-title":"ISRN Ophthalmol"},{"key":"10.1016\/j.ejmp.2022.08.001_b0105","doi-asserted-by":"crossref","unstructured":"COMS Group. Accuracy of Diagnosis of Choroidal Melanomas in the Collaborative Ocular Melanoma Study: COMS Report No. 1. Arch Ophthalmol 1990;108:1268\u201373. https:\/\/doi.org\/10.1001\/archopht.1990.01070110084030.","DOI":"10.1001\/archopht.1990.01070110084030"},{"issue":"5","key":"10.1016\/j.ejmp.2022.08.001_b0110","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ijrobp.2018.12.004","article-title":"Lens dose-response prediction modeling and cataract incidence in patients with retinoblastoma after lens-sparing or whole-eye radiation therapy","volume":"103","author":"Nguyen","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2022.08.001_b0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5301\/ejo.5000670","article-title":"Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study","volume":"26","author":"Finger","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ejmp.2022.08.001_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/ICU.0000000000000141","article-title":"Current treatments and preventive strategies for radiation retinopathy","volume":"26","author":"Reichstein","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ejmp.2022.08.001_b0125","first-page":"119","article-title":"Radiotherapy for ocular tumours","volume":"27","author":"Stannard","year":"2013","journal-title":"Radiotherapy for ocular tumours Eye"},{"key":"10.1016\/j.ejmp.2022.08.001_b0130","unstructured":"Sterns G, Faye E. Chapter 24. Low Vision. In: Riordan-Eva P, Cunningham E, editors. Vaughan Asbury\u2019s Gen. Ophthalmol. 18e ed., New York, NY: McGraw-Hill; 2011."},{"key":"10.1016\/j.ejmp.2022.08.001_b0135","unstructured":"COMS. COMS Manual of Procedures. Springfield, VA: 1991."},{"key":"10.1016\/j.ejmp.2022.08.001_b0140","unstructured":"Kline R. Coordinate localization of eye plaque for Collaborative Ocular Melanoma Study (COMS) n.d. http:\/\/rpc.mdanderson.org\/rpc\/credentialing\/COMS.htm (accessed February 28, 2022)."},{"issue":"2","key":"10.1016\/j.ejmp.2022.08.001_b0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43","volume":"22","author":"Nath","year":"1995","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.ejmp.2022.08.001_b0150","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2022.08.001_b0155","doi-asserted-by":"crossref","unstructured":"Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of Normal Tissue Complication Probability Models in the Clinic. Int J Radiat Oncol Biol Phys 2010;76:10\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1754.","DOI":"10.1016\/j.ijrobp.2009.07.1754"},{"key":"10.1016\/j.ejmp.2022.08.001_b0160","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.athoracsur.2015.11.024","article-title":"Adjust for multiple comparisons? it\u2019s not that simple","volume":"101","author":"Althouse","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ejmp.2022.08.001_b0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archopht.117.5.609","article-title":"Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma","volume":"117","author":"Gunduz","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ejmp.2022.08.001_b0170","doi-asserted-by":"crossref","unstructured":"Espensen CA, Appelt AL, Fog LS, Gothelf AB, Thariat J, Kiilgaard JF. Predicting visual acuity deterioration and radiation-induced toxicities after brachytherapy for choroidal melanomas. Cancers (Basel) 2019;11. https:\/\/doi.org\/10.3390\/cancers11081124.","DOI":"10.3390\/cancers11081124"},{"key":"10.1016\/j.ejmp.2022.08.001_b0175","doi-asserted-by":"crossref","unstructured":"Group. COMS. Ten-year follow up of fellow eyes enrolled in Colaborative Ocular Melanoma Study randomized trials: COMS report no. 22. Ophthalmology 2004;5:206\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2003.08.029.","DOI":"10.1097\/01.ieb.0000142780.51926.02"},{"key":"10.1016\/j.ejmp.2022.08.001_b0180","doi-asserted-by":"crossref","unstructured":"COMS Group. Incidence of Cataract and Outcomes after Cataract Surgery in the First 5 Years after Iodine 125 Brachytherapy in the Collaborative Ocular Melanoma Study COMS Report No. 27. Ophthalmology 2007;114:1363\u201371. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.ophtha.2006.10.039.","DOI":"10.1016\/j.ophtha.2006.10.039"},{"issue":"11","key":"10.1016\/j.ejmp.2022.08.001_b0185","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/eye.2012.158","article-title":"The effects of intraocular silicone oil placement prior to iodine 125 brachytherapy for uveal melanoma: A clinical case series","volume":"26","author":"Ahuja","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.ejmp.2022.08.001_b0190","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archophthalmol.2010.117","article-title":"Attenuation of iodine 125 radiation with vitreous substitutes in the treatment of uveal melanoma","volume":"128","author":"Oliver","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ejmp.2022.08.001_b0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijrobp.2014.02.021","article-title":"Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series","volume":"89","author":"McCannel","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.ejmp.2022.08.001_b0200","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1002\/mp.12430","article-title":"Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO","volume":"44","author":"Rivard","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2022.08.001_b0205","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1002\/mp.15045","article-title":"A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model","volume":"48","author":"Miras del R\u00edo","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2022.08.001_b0210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejmp.2020.07.019","article-title":"Personalized treatment planning in eye brachytherapy for ocular melanoma: Dosimetric analysis on ophthalmic structure at risk","volume":"76","author":"Itta","year":"2020","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2022.08.001_b0215","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1111\/aos.14663","article-title":"3D image-guided treatment planning for Ruthenium-106 brachytherapy of choroidal melanomas","volume":"99","author":"Espensen","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ejmp.2022.08.001_b0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejmp.2021.10.004","article-title":"Design and optimizing a novel ocular plaque brachytherapy with dual-core of 103Pd and 106Ru","volume":"91","author":"Sharifzadeh","year":"2021","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2022.08.001_b0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2021.11.007","article-title":"Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: A systematic review and a data pooled analysis","volume":"166","author":"Buonanno","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2022.08.001_b0230","doi-asserted-by":"crossref","unstructured":"Nath R, Bice WS, Butler WM, Chen Z, Meigooni AS, Narayana V, et al. AAPM Recommendations on Dose Prescription and Reporting Methods for Permanent Interstitial Brachytherapy for Prostate Cancer Report of AAPM Task Group 137. 2009.","DOI":"10.1118\/1.3246613"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179722020257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179722020257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:50:38Z","timestamp":1761105038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179722020257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"alternative-id":["S1120179722020257"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2022.08.001","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of dose to the macula, optic disc, and lens in relation to vision toxicities \u2013 A retrospective study using COMS eye plaques","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2022.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}